Clinical trial

Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study)

NCT06913907

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-04-10

PhasePHASE4

Study timeline

Study start (estimated)2025-04-10Date precision: day

Registry last updated2025-04-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritis (RA)unresolved

Interventions

Methotrexate (MTX)DRUG

Sponsors & collaborators

Keio Universitylead sponsor

Eisai Co., Ltd.collaborator

Mebix Inccollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06913907 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.